Bliss Kelly 4
4 · Teladoc Health, Inc. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Teladoc (TDOC) President Kelly Bliss Sells 26,647 Shares
What Happened
- Kelly Bliss, President, U.S. Group Health at Teladoc (TDOC), had multiple equity award conversions/vestings and a small open‑market sale. On Feb 27, 2026 several derivative awards were converted/treated as exercised (totaling multiple blocks: 3,488; 4,858; 36,610; 1,186; 5,198 shares). On March 1, 2026 she was recorded as receiving 181,661 award units and earning 27,458 performance stock units. On March 2, 2026 she sold 26,647 shares in the open market at $5.12 per share, generating $136,353 in proceeds.
- The conversions/exercises show $0 cash proceeds in the filing, indicating these were vestings/conversions of restricted stock units (RSUs) and performance stock units (PSUs), not cash option sales. The March 2 sale was a cash sale.
Key Details
- Transaction dates and prices:
- Feb 27, 2026: Multiple derivative exercises/conversions (3,488; 4,858; 36,610; 1,186; 5,198 shares) — listed with $0 proceeds (vest/convert).
- Mar 1, 2026: Grant/award recorded for 181,661 units (acquired at $0.00); 27,458 PSUs earned (per footnote).
- Mar 2, 2026: Open-market sale of 26,647 shares at $5.12/share = $136,353 proceeds.
- Shares sold to cover taxes: Footnote F3 states the sale(s) were shares sold to cover the tax withholding obligation related to vesting of PSU/RSU awards.
- Vesting notes: PSUs and RSUs convert one‑for‑one to common shares (F1, F2, F8, F12). Many awards vest one‑third on the indicated date (e.g., March 1, 2026) with the remainder vesting in eight substantially equal quarterly installments (F10, F11, F13).
- Shares owned after transaction: Not specified in the excerpt provided.
- Filing timeliness: Form 4 was filed March 3, 2026. The filing includes no indication of a late filing.
Context
- These filings reflect routine vesting and tax‑withholding related sales rather than a directional open‑market investment decision. The $136k sale corresponds to withholding/settlement of awards rather than a large discretionary liquidation. Conversions labeled as "M" or with $0 proceeds are best read as RSU/PSU vesting or conversion to common shares (one‑for‑one), not taxable option cash exercises.
Insider Transaction Report
Form 4
Bliss Kelly
President, U.S. Group Health
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-27+3,488→ 63,542 total - Exercise/Conversion
Common Stock
[F1]2026-02-27+4,858→ 68,400 total - Exercise/Conversion
Common Stock
[F1]2026-02-27+36,610→ 105,010 total - Exercise/Conversion
Common Stock
[F2]2026-02-27+1,186→ 106,196 total - Exercise/Conversion
Common Stock
[F2]2026-02-27+5,198→ 111,394 total - Sale
Common Stock
[F3]2026-03-02$5.12/sh−26,647$136,353→ 84,747 total - Exercise/Conversion
Restricted Stock Units
[F1][F4]2026-02-27−3,488→ 0 total→ Common Stock (3,488 underlying) - Exercise/Conversion
Restricted Stock Units
[F1][F5]2026-02-27−4,858→ 19,435 total→ Common Stock (4,858 underlying) - Exercise/Conversion
Restricted Stock Units
[F1][F6]2026-02-27−36,610→ 73,222 total→ Common Stock (36,610 underlying) - Exercise/Conversion
Performance Stock Units
[F2][F7]2026-02-27−1,186→ 0 total→ Common Stock (1,186 underlying) - Award
Performance Stock Units
[F8][F9][F10]2026-02-27+27,458→ 27,458 total→ Common Stock (27,458 underlying) - Exercise/Conversion
Performance Stock Units
[F2][F11]2026-02-27−5,198→ 22,260 total→ Common Stock (5,198 underlying) - Award
Restricted Stock Units
[F12][F13]2026-03-01+181,661→ 181,661 total→ Common Stock (181,661 underlying)
Footnotes (13)
- [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F10]The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F11]On March 1, 2026, the reporting person earned 27,458 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F12]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- [F13]One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F2]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
- [F6]On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F7]On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F8]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
- [F9]Performance award amount determined based on metrics in respect of the issuer's 2025 financial results.
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact|2026-03-03